OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,289 JPY | +0.31% |
|
+1.46% | +12.18% |
| 05-10 | Olympus Corporation announces an Equity Buyback for 60,000,000 shares, representing 5.15% for ¥100,000 million. | CI |
| 05-10 | Olympus Corporation authorizes a Buyback Plan. | CI |
| Sales 2024 | 936B 6.01B 480B | Sales 2025 * | 991B 6.36B 508B | Capitalization | 2,668B 17.12B 1,368B |
|---|---|---|---|---|---|
| Net income 2024 | 243B 1.56B 124B | Net income 2025 * | 109B 697M 55.7B | EV / Sales 2024 | 2.75 x |
| Net cash position 2024 * | 78.83B 506M 40.42B | Net cash position 2025 * | 127B 813M 64.91B | EV / Sales 2025 * | 2.56 x |
| P/E ratio 2024 |
11.1
x | P/E ratio 2025 * |
24.8
x | Employees | 32,844 |
| Yield 2024 * |
0.79% | Yield 2025 * |
0.87% | Free-Float | 94.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | +0.31% | ||
| 1 week | +1.46% | ||
| Current month | +4.02% | ||
| 1 month | +5.68% | ||
| 3 months | +4.62% | ||
| 6 months | +11.96% | ||
| Current year | +12.18% |
1 week
2 219.00
2 369.50
1 month
2 083.002 369.50
Current year
1 935.502 369.50
1 year
1 782.002 478.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
755.003 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 31/03/17 |
Yasuo Takeuchi
CHM | Chairman | 67 | 01/04/80 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 02/10/23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 61 | 31/05/19 |
Gary Pruden
BRD | Director/Board Member | 62 | 31/05/22 |
Yasushi Shingai
BRD | Director/Board Member | 68 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 0 M€ | +12.19% | ||
| 2.11% | 0 M€ | +13.64% | - | |
| 1.55% | 0 M€ | +13.17% | ||
| 1.23% | 0 M€ | +15.47% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 2,289 | +0.31% | 3,890,700 |
| 09/05/24 | 2,282 | +1.09% | 2,547,700 |
| 08/05/24 | 2,258 | -1.16% | 3,379,300 |
| 07/05/24 | 2,284 | +1.24% | 4,473,800 |
| 02/05/24 | 2,256 | +2.97% | 3,880,400 |
Delayed Quote Japan Exchange, May 10, 2024 at 07:00 am
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
06/08/2024
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
2,289
JPY
Average target price
2,456
JPY
Spread / Average Target
+7.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.18% | 17.12B | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- 7733 Stock
